Merit Historical Financial Ratios
| MMSI Stock | USD 103.90 0.24 0.23% |
Merit Medical is lately reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 64.66 will help investors to properly organize and evaluate Merit Medical Systems financial condition quickly.
Merit |
About Merit Financial Ratios Analysis
Merit Medical SystemsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Merit Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Merit financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Merit Medical history.
Merit Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Merit Medical Systems stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Merit Medical sales, a figure that is much harder to manipulate than other Merit Medical Systems multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Payout Ratio
Payout Ratio is the proportion of Merit Medical Systems earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of Merit Medical Systems dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating Merit Medical Systems is paying out more in dividends than it makes in net income.Most ratios from Merit Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. As of now, Merit Medical's Operating Cash Flow Per Share is increasing as compared to previous years. The Merit Medical's current Stock Based Compensation To Revenue is estimated to increase to 0.02, while Price To Sales Ratio is projected to decrease to 2.66.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 58.7 | 56.59 | 54.94 | 64.66 | PTB Ratio | 3.36 | 3.51 | 3.64 | 3.6 |
Merit Medical fundamentals Correlations
Click cells to compare fundamentals
Merit Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merit Medical fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.73 | 3.19 | 3.25 | 3.49 | 3.48 | 2.66 | |
| Ptb Ratio | 1.81 | 3.21 | 3.36 | 3.51 | 3.64 | 3.6 | |
| Days Sales Outstanding | 61.83 | 59.82 | 58.7 | 56.59 | 54.94 | 64.66 | |
| Book Value Per Share | 17.25 | 17.29 | 18.52 | 20.15 | 20.87 | 21.91 | |
| Free Cash Flow Yield | (0.002143) | 0.0377 | 0.0341 | 0.0173 | 0.0248 | 0.026 | |
| Operating Cash Flow Per Share | 1.41 | 2.98 | 2.62 | 2.01 | 2.52 | 2.65 | |
| Stock Based Compensation To Revenue | 0.009431 | 0.0149 | 0.015 | 0.0157 | 0.017 | 0.0178 | |
| Capex To Depreciation | 0.78 | 0.46 | 0.29 | 0.49 | 0.36 | 0.34 | |
| Pb Ratio | 1.81 | 3.21 | 3.36 | 3.51 | 3.64 | 3.6 | |
| Ev To Sales | 2.21 | 3.58 | 3.48 | 3.67 | 3.72 | 2.84 | |
| Free Cash Flow Per Share | (0.0669) | 2.09 | 2.12 | 1.22 | 1.88 | 1.98 | |
| Roic | (0.12) | (0.0352) | 0.0423 | 0.0583 | 0.0516 | 0.0381 | |
| Inventory Turnover | 2.49 | 2.84 | 2.66 | 2.38 | 2.22 | 2.19 | |
| Net Income Per Share | 0.099 | (0.18) | 0.86 | 1.31 | 1.64 | 1.72 | |
| Days Of Inventory On Hand | 146.46 | 128.45 | 137.43 | 153.65 | 164.68 | 157.37 | |
| Payables Turnover | 10.3 | 11.29 | 10.6 | 9.22 | 10.21 | 7.94 | |
| Research And Ddevelopement To Revenue | 0.066 | 0.0597 | 0.0663 | 0.0656 | 0.0658 | 0.0446 | |
| Capex To Revenue | 0.0819 | 0.0511 | 0.026 | 0.0391 | 0.0292 | 0.0277 | |
| Cash Per Share | 1.29 | 0.8 | 1.03 | 1.21 | 10.23 | 10.74 | |
| Pocfratio | 22.1 | 18.62 | 23.76 | 35.1 | 30.14 | 35.75 | |
| Interest Coverage | (5.29) | (6.26) | 11.58 | 13.81 | 7.99 | 7.59 | |
| Capex To Operating Cash Flow | 1.05 | 0.3 | 0.19 | 0.39 | 0.25 | 0.24 | |
| Pfcf Ratio | (466.73) | 26.53 | 29.32 | 57.92 | 40.34 | 42.36 | |
| Days Payables Outstanding | 35.45 | 32.33 | 34.45 | 39.57 | 35.74 | 45.0 | |
| Income Quality | 14.27 | (16.79) | 3.04 | 1.53 | 1.54 | 1.27 | |
| Roe | 0.005738 | (0.0103) | 0.0466 | 0.0651 | 0.0785 | 0.0525 | |
| Ev To Operating Cash Flow | 28.26 | 20.91 | 25.44 | 36.94 | 32.24 | 41.66 | |
| Pe Ratio | 315.44 | (312.62) | 72.19 | 53.84 | 46.34 | 40.92 | |
| Return On Tangible Assets | 0.005685 | (0.0106) | 0.0501 | 0.0725 | 0.0584 | 0.046 | |
| Ev To Free Cash Flow | (596.87) | 29.79 | 31.39 | 60.96 | 43.15 | 45.3 | |
| Earnings Yield | 0.00317 | (0.003199) | 0.0139 | 0.0186 | 0.0216 | 0.0301 | |
| Intangibles To Total Assets | 0.49 | 0.45 | 0.44 | 0.41 | 0.3 | 0.16 | |
| Net Debt To E B I T D A | 3.96 | 3.68 | 1.61 | 1.16 | 1.31 | 1.1 | |
| Tangible Book Value Per Share | 2.75 | 4.1 | 6.39 | 8.96 | 8.58 | 9.0 | |
| Receivables Turnover | 5.9 | 6.1 | 6.22 | 6.45 | 6.64 | 5.11 | |
| Graham Number | 6.2 | 8.31 | 18.96 | 24.38 | 27.75 | 29.13 | |
| Shareholders Equity Per Share | 17.25 | 17.29 | 18.52 | 20.15 | 20.87 | 21.91 |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.